Report Detail

Request for Sample of this report

Pharma & Healthcare Global Functional Dyspepsia Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4619557
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
According to our (Global Info Research) latest study, the global Functional Dyspepsia Drug market size was valued at US$ 6307 million in 2023 and is forecast to a readjusted size of USD 7602 million by 2030 with a CAGR of 2.7% during review period.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
This report is a detailed and comprehensive analysis for global Functional Dyspepsia Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Functional Dyspepsia Drug market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Functional Dyspepsia Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Functional Dyspepsia Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Functional Dyspepsia Drug market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Functional Dyspepsia Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Functional Dyspepsia Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Sumitomo, Cadila Pharmaceuticals, Teva, Johnson & Johnson, Pfizer, Sanofi, AstraZeneca, Jiangsu Aosaikang Pharma, Eisai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Functional Dyspepsia Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
Market segment by Application
Hospitals
Drugstores
Major players covered
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Functional Dyspepsia Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Functional Dyspepsia Drug, with price, sales quantity, revenue, and global market share of Functional Dyspepsia Drug from 2019 to 2024.
Chapter 3, the Functional Dyspepsia Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Functional Dyspepsia Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Functional Dyspepsia Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Functional Dyspepsia Drug.
Chapter 14 and 15, to describe Functional Dyspepsia Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Functional Dyspepsia Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Prokinetic Drugs
    • 1.3.3 Gastric Antisecretory Drugs
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Functional Dyspepsia Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Drugstores
  • 1.5 Global Functional Dyspepsia Drug Market Size & Forecast
    • 1.5.1 Global Functional Dyspepsia Drug Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Functional Dyspepsia Drug Sales Quantity (2019-2030)
    • 1.5.3 Global Functional Dyspepsia Drug Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Functional Dyspepsia Drug Product and Services
    • 2.1.4 Bayer Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bayer Recent Developments/Updates
  • 2.2 Sumitomo
    • 2.2.1 Sumitomo Details
    • 2.2.2 Sumitomo Major Business
    • 2.2.3 Sumitomo Functional Dyspepsia Drug Product and Services
    • 2.2.4 Sumitomo Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Sumitomo Recent Developments/Updates
  • 2.3 Cadila Pharmaceuticals
    • 2.3.1 Cadila Pharmaceuticals Details
    • 2.3.2 Cadila Pharmaceuticals Major Business
    • 2.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Product and Services
    • 2.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Cadila Pharmaceuticals Recent Developments/Updates
  • 2.4 Teva
    • 2.4.1 Teva Details
    • 2.4.2 Teva Major Business
    • 2.4.3 Teva Functional Dyspepsia Drug Product and Services
    • 2.4.4 Teva Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Teva Recent Developments/Updates
  • 2.5 Johnson & Johnson
    • 2.5.1 Johnson & Johnson Details
    • 2.5.2 Johnson & Johnson Major Business
    • 2.5.3 Johnson & Johnson Functional Dyspepsia Drug Product and Services
    • 2.5.4 Johnson & Johnson Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Johnson & Johnson Recent Developments/Updates
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Functional Dyspepsia Drug Product and Services
    • 2.6.4 Pfizer Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Pfizer Recent Developments/Updates
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Functional Dyspepsia Drug Product and Services
    • 2.7.4 Sanofi Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Sanofi Recent Developments/Updates
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Functional Dyspepsia Drug Product and Services
    • 2.8.4 AstraZeneca Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 AstraZeneca Recent Developments/Updates
  • 2.9 Jiangsu Aosaikang Pharma
    • 2.9.1 Jiangsu Aosaikang Pharma Details
    • 2.9.2 Jiangsu Aosaikang Pharma Major Business
    • 2.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product and Services
    • 2.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Jiangsu Aosaikang Pharma Recent Developments/Updates
  • 2.10 Eisai
    • 2.10.1 Eisai Details
    • 2.10.2 Eisai Major Business
    • 2.10.3 Eisai Functional Dyspepsia Drug Product and Services
    • 2.10.4 Eisai Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Eisai Recent Developments/Updates
  • 2.11 Kyowa Kirin Pharmaceuticals
    • 2.11.1 Kyowa Kirin Pharmaceuticals Details
    • 2.11.2 Kyowa Kirin Pharmaceuticals Major Business
    • 2.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product and Services
    • 2.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
  • 2.12 Hanmi Pharm
    • 2.12.1 Hanmi Pharm Details
    • 2.12.2 Hanmi Pharm Major Business
    • 2.12.3 Hanmi Pharm Functional Dyspepsia Drug Product and Services
    • 2.12.4 Hanmi Pharm Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Hanmi Pharm Recent Developments/Updates

3 Competitive Environment: Functional Dyspepsia Drug by Manufacturer

  • 3.1 Global Functional Dyspepsia Drug Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Functional Dyspepsia Drug Revenue by Manufacturer (2019-2024)
  • 3.3 Global Functional Dyspepsia Drug Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Functional Dyspepsia Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Functional Dyspepsia Drug Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Functional Dyspepsia Drug Manufacturer Market Share in 2023
  • 3.5 Functional Dyspepsia Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Functional Dyspepsia Drug Market: Region Footprint
    • 3.5.2 Functional Dyspepsia Drug Market: Company Product Type Footprint
    • 3.5.3 Functional Dyspepsia Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Functional Dyspepsia Drug Market Size by Region
    • 4.1.1 Global Functional Dyspepsia Drug Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Functional Dyspepsia Drug Consumption Value by Region (2019-2030)
    • 4.1.3 Global Functional Dyspepsia Drug Average Price by Region (2019-2030)
  • 4.2 North America Functional Dyspepsia Drug Consumption Value (2019-2030)
  • 4.3 Europe Functional Dyspepsia Drug Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Functional Dyspepsia Drug Consumption Value (2019-2030)
  • 4.5 South America Functional Dyspepsia Drug Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Functional Dyspepsia Drug Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Functional Dyspepsia Drug Sales Quantity by Type (2019-2030)
  • 5.2 Global Functional Dyspepsia Drug Consumption Value by Type (2019-2030)
  • 5.3 Global Functional Dyspepsia Drug Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Functional Dyspepsia Drug Sales Quantity by Application (2019-2030)
  • 6.2 Global Functional Dyspepsia Drug Consumption Value by Application (2019-2030)
  • 6.3 Global Functional Dyspepsia Drug Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Functional Dyspepsia Drug Sales Quantity by Type (2019-2030)
  • 7.2 North America Functional Dyspepsia Drug Sales Quantity by Application (2019-2030)
  • 7.3 North America Functional Dyspepsia Drug Market Size by Country
    • 7.3.1 North America Functional Dyspepsia Drug Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Functional Dyspepsia Drug Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Functional Dyspepsia Drug Sales Quantity by Type (2019-2030)
  • 8.2 Europe Functional Dyspepsia Drug Sales Quantity by Application (2019-2030)
  • 8.3 Europe Functional Dyspepsia Drug Market Size by Country
    • 8.3.1 Europe Functional Dyspepsia Drug Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Functional Dyspepsia Drug Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Functional Dyspepsia Drug Market Size by Region
    • 9.3.1 Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Functional Dyspepsia Drug Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Functional Dyspepsia Drug Sales Quantity by Type (2019-2030)
  • 10.2 South America Functional Dyspepsia Drug Sales Quantity by Application (2019-2030)
  • 10.3 South America Functional Dyspepsia Drug Market Size by Country
    • 10.3.1 South America Functional Dyspepsia Drug Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Functional Dyspepsia Drug Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Functional Dyspepsia Drug Market Size by Country
    • 11.3.1 Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Functional Dyspepsia Drug Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Functional Dyspepsia Drug Market Drivers
  • 12.2 Functional Dyspepsia Drug Market Restraints
  • 12.3 Functional Dyspepsia Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Functional Dyspepsia Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Functional Dyspepsia Drug
  • 13.3 Functional Dyspepsia Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Functional Dyspepsia Drug Typical Distributors
  • 14.3 Functional Dyspepsia Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Functional Dyspepsia Drug. Industry analysis & Market Report on Functional Dyspepsia Drug is a syndicated market report, published as Global Functional Dyspepsia Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Functional Dyspepsia Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,599.56
    		3,899.34
    		5,199.12
    		3,118.08
    		4,677.12
    		6,236.16
    		496,944.00
    		745,416.00
    		993,888.00
    		291,310.80
    		436,966.20
    		582,621.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo